Secretion of 6β-hydroxycortisol by normal human adrenals and adrenocortical adenomas

Nikolette Szucs, I. Varga, A. Patócs, Miklós Tóth, E. Gláz, K. Rácz

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Although 6β-hydroxycortisol (6βOHF) is usually considered a cortisol metabolite produced by the liver, a few reports suggest that it may also originate from extrahepatic sources. To examine whether human adrenal cells are capable of 6β-hydroxylating cortisol, we measured 6βOHF secretion with a radioimmunoassay method in isolated human adrenal cell systems obtained from three normal adrenals, four nonhyperfunctioning adrenocortical adenomas, two adrenal adenomas causing Cushing's syndrome, and five aldosterone (Aldo)-producing adenomas. Cells were examined both under basal conditions and after stimulation with adrenocorticotrophic hormone (ACTH). In addition, 6βOHF concentrations were determined in inferior vena cava and suprarenal vein plasma samples obtained from the side of nonhyperfunctioning adrenal adenomas (five patients) and aldosterone-producing adenomas (five patients). Under basal incubation conditions, 6βOHF secretion, expressed as a percent of cortisol secretion, was between 0.5 and 2.0% in normal adrenal cells, between 1.0 and 7% in cells from nonhyperfunctioning adenomas, 12 and 15% in cells from Cushing's syndrome patients, and between 2.6 and 3.9% in cells from aldosterone-producing adenomas. In these cells, increasing doses of ACTH produced a dose-dependent stimulation of both 6βOHF and cortisol secretion. The 6βOHF concentration in suprarenal vein samples obtained from the side of adenomas was markedly increased; the suprarenal vein/inferior vena cava 6βOHF ratios were 13.1±2.1 (mean±S.E.) in the case of nonhyperfunctioning adenomas and 17.8±4.5 in the case of aldosterone-producing adenomas. These results firmly suggest that 6βOHF is not only a hepatic metabolite, but also a secretory product of human adrenals and that similarly to cortisol, its secretion may be controlled by ACTH.

Original languageEnglish
Pages (from-to)477-482
Number of pages6
JournalSteroids
Volume68
Issue number5
DOIs
Publication statusPublished - May 1 2003

Fingerprint

Adrenocortical Adenoma
Adenoma
Hydrocortisone
Aldosterone
Adrenocorticotropic Hormone
Metabolites
Veins
Cushing Syndrome
Inferior Vena Cava
Liver
Plasmas
Radioimmunoassay

Keywords

  • 6β-Hydroxycortisol
  • Adrenocortical adenoma cells
  • Corticosteroid biosynthesis
  • Cortisol
  • Human adrenal gland

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Molecular Biology

Cite this

Secretion of 6β-hydroxycortisol by normal human adrenals and adrenocortical adenomas. / Szucs, Nikolette; Varga, I.; Patócs, A.; Tóth, Miklós; Gláz, E.; Rácz, K.

In: Steroids, Vol. 68, No. 5, 01.05.2003, p. 477-482.

Research output: Contribution to journalArticle

@article{0cdea6cd2aa843ba987d44c80f6606e4,
title = "Secretion of 6β-hydroxycortisol by normal human adrenals and adrenocortical adenomas",
abstract = "Although 6β-hydroxycortisol (6βOHF) is usually considered a cortisol metabolite produced by the liver, a few reports suggest that it may also originate from extrahepatic sources. To examine whether human adrenal cells are capable of 6β-hydroxylating cortisol, we measured 6βOHF secretion with a radioimmunoassay method in isolated human adrenal cell systems obtained from three normal adrenals, four nonhyperfunctioning adrenocortical adenomas, two adrenal adenomas causing Cushing's syndrome, and five aldosterone (Aldo)-producing adenomas. Cells were examined both under basal conditions and after stimulation with adrenocorticotrophic hormone (ACTH). In addition, 6βOHF concentrations were determined in inferior vena cava and suprarenal vein plasma samples obtained from the side of nonhyperfunctioning adrenal adenomas (five patients) and aldosterone-producing adenomas (five patients). Under basal incubation conditions, 6βOHF secretion, expressed as a percent of cortisol secretion, was between 0.5 and 2.0{\%} in normal adrenal cells, between 1.0 and 7{\%} in cells from nonhyperfunctioning adenomas, 12 and 15{\%} in cells from Cushing's syndrome patients, and between 2.6 and 3.9{\%} in cells from aldosterone-producing adenomas. In these cells, increasing doses of ACTH produced a dose-dependent stimulation of both 6βOHF and cortisol secretion. The 6βOHF concentration in suprarenal vein samples obtained from the side of adenomas was markedly increased; the suprarenal vein/inferior vena cava 6βOHF ratios were 13.1±2.1 (mean±S.E.) in the case of nonhyperfunctioning adenomas and 17.8±4.5 in the case of aldosterone-producing adenomas. These results firmly suggest that 6βOHF is not only a hepatic metabolite, but also a secretory product of human adrenals and that similarly to cortisol, its secretion may be controlled by ACTH.",
keywords = "6β-Hydroxycortisol, Adrenocortical adenoma cells, Corticosteroid biosynthesis, Cortisol, Human adrenal gland",
author = "Nikolette Szucs and I. Varga and A. Pat{\'o}cs and Mikl{\'o}s T{\'o}th and E. Gl{\'a}z and K. R{\'a}cz",
year = "2003",
month = "5",
day = "1",
doi = "10.1016/S0039-128X(03)00050-3",
language = "English",
volume = "68",
pages = "477--482",
journal = "Steroids",
issn = "0039-128X",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Secretion of 6β-hydroxycortisol by normal human adrenals and adrenocortical adenomas

AU - Szucs, Nikolette

AU - Varga, I.

AU - Patócs, A.

AU - Tóth, Miklós

AU - Gláz, E.

AU - Rácz, K.

PY - 2003/5/1

Y1 - 2003/5/1

N2 - Although 6β-hydroxycortisol (6βOHF) is usually considered a cortisol metabolite produced by the liver, a few reports suggest that it may also originate from extrahepatic sources. To examine whether human adrenal cells are capable of 6β-hydroxylating cortisol, we measured 6βOHF secretion with a radioimmunoassay method in isolated human adrenal cell systems obtained from three normal adrenals, four nonhyperfunctioning adrenocortical adenomas, two adrenal adenomas causing Cushing's syndrome, and five aldosterone (Aldo)-producing adenomas. Cells were examined both under basal conditions and after stimulation with adrenocorticotrophic hormone (ACTH). In addition, 6βOHF concentrations were determined in inferior vena cava and suprarenal vein plasma samples obtained from the side of nonhyperfunctioning adrenal adenomas (five patients) and aldosterone-producing adenomas (five patients). Under basal incubation conditions, 6βOHF secretion, expressed as a percent of cortisol secretion, was between 0.5 and 2.0% in normal adrenal cells, between 1.0 and 7% in cells from nonhyperfunctioning adenomas, 12 and 15% in cells from Cushing's syndrome patients, and between 2.6 and 3.9% in cells from aldosterone-producing adenomas. In these cells, increasing doses of ACTH produced a dose-dependent stimulation of both 6βOHF and cortisol secretion. The 6βOHF concentration in suprarenal vein samples obtained from the side of adenomas was markedly increased; the suprarenal vein/inferior vena cava 6βOHF ratios were 13.1±2.1 (mean±S.E.) in the case of nonhyperfunctioning adenomas and 17.8±4.5 in the case of aldosterone-producing adenomas. These results firmly suggest that 6βOHF is not only a hepatic metabolite, but also a secretory product of human adrenals and that similarly to cortisol, its secretion may be controlled by ACTH.

AB - Although 6β-hydroxycortisol (6βOHF) is usually considered a cortisol metabolite produced by the liver, a few reports suggest that it may also originate from extrahepatic sources. To examine whether human adrenal cells are capable of 6β-hydroxylating cortisol, we measured 6βOHF secretion with a radioimmunoassay method in isolated human adrenal cell systems obtained from three normal adrenals, four nonhyperfunctioning adrenocortical adenomas, two adrenal adenomas causing Cushing's syndrome, and five aldosterone (Aldo)-producing adenomas. Cells were examined both under basal conditions and after stimulation with adrenocorticotrophic hormone (ACTH). In addition, 6βOHF concentrations were determined in inferior vena cava and suprarenal vein plasma samples obtained from the side of nonhyperfunctioning adrenal adenomas (five patients) and aldosterone-producing adenomas (five patients). Under basal incubation conditions, 6βOHF secretion, expressed as a percent of cortisol secretion, was between 0.5 and 2.0% in normal adrenal cells, between 1.0 and 7% in cells from nonhyperfunctioning adenomas, 12 and 15% in cells from Cushing's syndrome patients, and between 2.6 and 3.9% in cells from aldosterone-producing adenomas. In these cells, increasing doses of ACTH produced a dose-dependent stimulation of both 6βOHF and cortisol secretion. The 6βOHF concentration in suprarenal vein samples obtained from the side of adenomas was markedly increased; the suprarenal vein/inferior vena cava 6βOHF ratios were 13.1±2.1 (mean±S.E.) in the case of nonhyperfunctioning adenomas and 17.8±4.5 in the case of aldosterone-producing adenomas. These results firmly suggest that 6βOHF is not only a hepatic metabolite, but also a secretory product of human adrenals and that similarly to cortisol, its secretion may be controlled by ACTH.

KW - 6β-Hydroxycortisol

KW - Adrenocortical adenoma cells

KW - Corticosteroid biosynthesis

KW - Cortisol

KW - Human adrenal gland

UR - http://www.scopus.com/inward/record.url?scp=0038205664&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038205664&partnerID=8YFLogxK

U2 - 10.1016/S0039-128X(03)00050-3

DO - 10.1016/S0039-128X(03)00050-3

M3 - Article

C2 - 12798499

AN - SCOPUS:0038205664

VL - 68

SP - 477

EP - 482

JO - Steroids

JF - Steroids

SN - 0039-128X

IS - 5

ER -